Delivery Order SPE2DB20D1109-SPE2DB25FN82U
Award Date
4/2/25
Potential Completion Date
4/23/25
Potential Value
$4.9K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $16,267.00, is a Firm Fixed Price Delivery Order for the KEDRAB 1,500 UNIT/10 ML VIAL 10ML product. The contract has an ultimate completion date of April 24, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $14,712.20, is for the delivery of 1,500 units of the medication KEDRAB (10 ML vial) to support military healthcare programs. It is a firm fixed-price delivery order contract with a completion date of March 21, 2025. The contract is not designated as a set-aside award. AmerisourceBergen holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,626.70 delivery order contract is for the supply of KEDRAB, a 1,500 unit/10 ML vial medication, with a performance period ending on April 24, 2025. The contract is a firm fixed-price, non-set-aside award. AmerisourceBergen Drug Corp holds a substantial $999,999,999.00 Indefinite Delivery Contract (IDC) with the...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract has an award value of $1,626.70 and is for the delivery of KEDRAB, a 1,500 unit/10 ML vial medical product, with a period of performance through April 1, 2025. This is a delivery order contract with a firm fixed price pricing type. The contract is not designated with a set-aside. Amerisourcebergen holds a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,990.36, is a Delivery Order for the supply of KEDRAB 300 UNIT/2 ML VIAL 2ML, with an ultimate completion date of April 28, 2025. The contract is Firm Fixed Price and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery...
This is a $3,253.40 firm fixed price delivery order contract awarded by the Defense Logistics Agency's (DLA) Medical Supply Chain to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 1,500 units of the medication KEDRAB 10 ML vial. The award has an ultimate completion date of May 2, 2025. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,843.20 firm fixed-price delivery order is for the supply of KEDRAB 300 UNIT/2 ML VIAL 2ML, a pharmaceutical product. The contract has an ultimate completion date of October 18, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award, valued at $3,248.76, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The contract is a delivery order for the supply of 1,500 units of the KEDRAB 10 ML vial, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of September 30, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $3,253.40, is for the delivery of KEDRAB 1,500 unit/10 mL vials. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of April 18, 2025. The award was made on March 28, 2025, and the contract has no set-aside designation, indicating open competition. As a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of KEDRAB 300 UNIT/2 ML VIAL 2ML medical products. The $1,995.18 fixed-price contract has a period of performance through March 11, 2025. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical...